US 8686184
Neprilysin inhibitors
granted A61PA61P1/12A61P13/12
Quick answer
US patent 8686184 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P1/12, A61P13/12, A61P21/02, A61P25/00